Gastroenterology review and perspective: The role of cross-sectional imaging in evaluating bowel damage in Crohn disease

American Journal of Roentgenology

Volumn 197, Issue 1, 2011, Pages 42-49

  Pariente, Benjamin ^a   Peyrin Biroulet, Laurent ^b   Cohen, Louis ^c   Zagdanski, Anne Marie ^a   Colombel, Jean Frédéric ^d  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c MOUNT SINAI HOSPITAL   (United States)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Bowel damage; Crohn disease; CT; MRI; Ultrasound

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; CONTRAST MEDIUM; GADOLINIUM; GLUCAGON; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MACROGOL; SCOPOLAMINE BUTYL BROMIDE; TUMOR NECROSIS FACTOR ANTIBODY;

ABDOMINAL ABSCESS; ABDOMINAL RADIOGRAPHY; ABDOMINAL SURGERY; ANUS FISTULA; CANCER RISK; CAPSULE ENDOSCOPY; COMPUTER ASSISTED ENTEROGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; DIGESTIVE SYSTEM FISTULA; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPY; ENTERITIS; ENTEROPATHY; GASTROINTESTINAL RADIOGRAPHY; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; INTESTINE STENOSIS; LEMANN SCORE; NUCLEAR MAGNETIC RESONANCE ENTEROGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERISTALSIS; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; RADIATION HAZARD; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STANDARD; TREATMENT RESPONSE;

EID: 79960531736     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.6632     Document Type: Review

References (70)

1. Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health. Inflamm Bowel Dis 2010; 16:15-22
2. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010; 105:289-297
3. Crohn BB, Ginzburg L, Openheimer GD. Regional ileitis: a clinical and pathological entity. JAMA 1932; 99:1323-1329
4. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49:777-782 (Pubitemid 33096034)
5. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8:244-250 (Pubitemid 34784976)
6. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 2010; 139:1147-1155
7. Fraquelli M, Colli A, Casazza G, et al. Role of US in detection of Crohn disease: meta-analysis. Radiology 2005; 236:95-101 (Pubitemid 40853300)
8. Paredes JM, Ripolles T, Cortes X, et al. Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's Disease. Dig Dis Sci 2010; 55:404-410
9. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008; 247:64-79
10. Johnson KT, Hara AK, Johnson CD. Evaluation of colitis: usefulness of CT enterography technique. Emerg Radiol 2009; 16:277-282
11. Booya F, Fletcher JG, Huprich JE, et al. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology 2006; 241:787-795 (Pubitemid 46190545)
12. Bodily KD, Fletcher JG, Solem CA, et al. Crohn disease: mural attenuation and thickness at contrast- enhanced CT enterography - correlation with endoscopic and histologic findings of inflammation. Radiology 2006; 238:505-516 (Pubitemid 43134363)
13. Colombel JF, Solem CA, Sandborn WJ, et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 2006; 55:1561-1567 (Pubitemid 44629202)
14. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010; 4:7-27
15. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2000; 25:219-228 (Pubitemid 30304973)
16. Zappa M, Stefanescu C, Cazals-Hatem D, Bretagnol F, Deschamps L, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 2011; 17:984-993
17. Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology 2009; 251:751-761
18. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR 2009; 193:113-121
19. Schmidt S, Lepori D, Meuwly JY, et al. Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of "sign-by-sign" correlation. Eur Radiol 2003; 13:1303-1311
20. Gasche C, Moser G, Turetschek K, et al. Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut 1999; 44:112-117 (Pubitemid 29143290)
21. Parente F, Greco S, Molteni M, et al. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther 2003; 18:1009-1016 (Pubitemid 37475961)
22. Voderholzer WA, Beinhoelzl J, Rogalla P, et al. Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut 2005; 54:369-373 (Pubitemid 40299093)
23. Solem CA, Loftus EV Jr, Fletcher JG, et al. Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008; 68:255-266 (Pubitemid 352024383)
24. Chiorean MV, Sandrasegaran K, Saxena R, et al. Correlation of CT enteroclysis with surgical pathology in Crohn's disease. Am J Gastroenterol 2007; 102:2541-2550 (Pubitemid 47631798)
25. Bourreille A, Ignjatovic A, Aabakken L, et al. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy 2009; 41:618-637
26. Tillack C, Seiderer J, Brand S, et al. Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease. Inflamm Bowel Dis 2008; 14:1219-1228
27. Florie J, Horsthuis K, Hommes DW, et al. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease. Clin Gastroenterol Hepatol 2005; 3:1221-1228 (Pubitemid 41797674)
28. Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2-versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2006; 238:517-530 (Pubitemid 43134364)
29. Martin DR, Danrad R, Herrmann K, Semelka RC, Hussain SM. Magnetic resonance imaging of the gastrointestinal tract. Top Magn Reson Imaging 2005; 16:77-98 (Pubitemid 43186779)
30. Maconi G, Sampietro GM, Parente F, et al. Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study. Am J Gastroenterol 2003; 98:1545-1555 (Pubitemid 36875346)
31. Martinez MJ, Ripolles T, Paredes JM, Blanc E, Marti-Bonmati L. Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI. Abdom Imaging 2009; 34:141-148
32. Parente F, Greco S, Molteni M, et al. Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn's disease: a prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy. Gut 2004; 53:1652-1657 (Pubitemid 39434111)
33. Vogel J, da Luz Moreira A, Baker M, et al. CT enterography for Crohn's disease: accurate preoperative diagnostic imaging. Dis Colon Rectum 2007; 50:1761-1769 (Pubitemid 350077091)
34. Bruining DH, Siddiki HA, Fletcher JG, et al. Prevalence of penetrating disease and extraintestinal manifestations of Crohn's disease detected with CT enterography. Inflamm Bowel Dis 2008; 14:1701-1706
35. Booya F, Akram S, Fletcher JG, et al. CT enterography and fistulizing Crohn's disease: clinical benefit and radiographic findings. Abdom Imaging 2009; 34:467-475
36. Pilleul F, Godefroy C, Yzebe-Beziat D, et al. Magnetic resonance imaging in Crohn's disease. Gastroenterol Clin Biol 2005; 29:803-808 (Pubitemid 41411360)
37. Parente F, Maconi G, Bollani S, et al. Bowel ultrasound in assessment of Crohn's disease and detection of related small bowel strictures: a prospective comparative study versus x ray and intraoperative findings. Gut 2002; 50:490-495 (Pubitemid 34638867)
38. Thoeni RF, Cello JP. CT imaging of colitis. Radiology 2006; 240:623-638 (Pubitemid 44267317)
39. Felt-Bersma RJ. Endoanal ultrasound in perianal fistulas and abscesses. Dig Liver Dis 2006; 38:537-543 (Pubitemid 44356243)
40. Ardizzone S, Maconi G, Colombo E, et al. Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis 2004; 10:91-96 (Pubitemid 38332167)
41. Ziech M, Felt-Bersma R, Stoker J. Imaging of perianal fistulas. Clin Gastroenterol Hepatol 2009; 7:1037-1045
42. Domkundwar SV, Shinagare AB. Role of transcutaneous perianal ultrasonography in evaluation of fistulas in ano. J Ultrasound Med 2007; 26:29-36 (Pubitemid 46080073)
43. Maconi G, Ardizzone S, Greco S, et al. Transperineal ultrasound in the detection of perianal and rectovaginal fistulae in Crohn's disease. Am J Gastroenterol 2007; 102:2214-2219 (Pubitemid 47493846)
44. Stewart LK, McGee J, Wilson SR. Transperineal and transvaginal sonography of perianal inflammatory disease. AJR 2001; 177:627-632 (Pubitemid 32802350)
45. Wedemeyer J, Kirchhoff T, Sellge G, et al. Transcutaneous perianal sonography: a sensitive method for the detection of perianal inflammatory lesions in Crohn's disease. World J Gastroenterol 2004; 10:2859-2863 (Pubitemid 39303005)
46. Yousem DM, Fishman EK, Jones B. Crohn disease: perirectal and perianal findings at CT. Radiology 1988; 167:331-334
47. Schratter-Sehn AU, Lochs H, Vogelsang H, et al. Endoscopic ultrasonography versus computed tomography in the differential diagnosis of perianorectal complications in Crohn's disease. Endoscopy 1993; 25:582-586 (Pubitemid 24002733)
48. Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001; 121:1064-1072 (Pubitemid 33022085)
49. Beets-Tan RG, Beets GL, van der Hoop AG, et al. Preoperative MR imaging of anal fistulas: does it really help the surgeon? Radiology 2001; 218:75-84 (Pubitemid 32151275)
50. Buchanan G, Halligan S, Williams A, et al. Effect of MRI on clinical outcome of recurrent fistula-in-ano. Lancet 2002; 360:1661-1662 (Pubitemid 35379740)
51. Van Assche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 2003; 98:332-339 (Pubitemid 36232382)
52. Karmiris K, Bielen D, Vanbeckevoort D, Vermeire S, Coremans G, et al. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 2011; 9:130-136
53. Savoye-Collet C, Savoye G, Koning E, Dacher JN, Lerebours E. Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy. Inflamm Bowel Dis [Epub 2010 Nov 29]
54. Ng SC, Plamondon S, Gupta A, et al. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas. Am J Gastroenterol 2009; 104:2973-2986
55. Migaleddu V, Scanu AM, Quaia E, et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease. Gastroenterology 2009; 137:43-52
56. Brenner DJ, Hall EJ. Computed tomography: an increasing source of radiation exposure. N Engl J Med 2007; 357:2277-2284 (Pubitemid 350190758)
57. Desmond AN, O'Regan K, Curran C, et al. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut 2008; 57:1524-1529
58. Peloquin JM, Pardi DS, Sandborn WJ, et al. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2008; 103:2015-2022
59. Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm Bowel Dis [Epub 2010 Nov 8]
60. Rimola J, Rodriguez S, Garcia-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009; 58:1113-1120
61. Rimola J, Ordas I, Rodriguez S, Garcia-Bosch O, Aceituno M, et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis [Epub 2010 Nov 8]
62. Oussalah A, Laurent V, Bruot O, et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010; 59:1056-1065
63. Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971; 14:706-720
64. van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 1995; 34[suppl 2]:74-78
65. St. Clair EW, van der Heijde DM, Smolen JS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004; 50:3432-3443 (Pubitemid 39488667)
66. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial). Ann Rheum Dis 2007; 66:1227-1232 (Pubitemid 47309742)
67. Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, et al. (2010) Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis [Epub 2010 Nov 28]
68. Peyrin-Biroulet L, Loftus EV, Harmsen WS, et al. Cumulative incidence of and risk factors for major abdominal surgery in a population-based cohort of Crohn's disease. Gastroenterology 2010; 138[suppl 2]:S1184
69. D'Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008; 371:660-667 (Pubitemid 351284485)
70. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. Early Crohn disease: a proposed definition for use in disease-modification trials. Gut 2010; 59:141-147